Pamela P. Palmer, Chief Medical Officer at ACELRX PHARMACEUTICALS INC (ACRX), bought 10,000 shares at $2.95 ($30K) on 2017-08-22, disclosed to the SEC on 2017-08-22.
Open-market purchase of $30k ACRX by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ACRX | BUY | 2018-11-19 | $49K | — | Filing → |
| ACRX | BUY | 2018-08-06 | $102K | — | Filing → |
| ACRX | BUY | 2011-06-13 | $41K | — | Filing → |